Quarterly Report Q1 2018

June 6, 2018

Prometic reports its 2018 first quarter highlights and financial results

  • Q1 results support expected 2018 full year spending decrease of approximately $15M
  • Sale of excess plasma inventory xompleted in April contributing $14M to proforma cash runway of $91M
  • Clinical programs streamlined to manage costs for balance of 2018
  • Continued positive clinical activity demonstrated by PBI-4050 to catalyze partnership discussions
Previous Flipbook
Notice of Annual and Special Meeting of Shareholders and Management Information Circular March 22, 2018
Notice of Annual and Special Meeting of Shareholders and Management Information Circular March 22, 2018

No More Flipbooks